The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Tyra Biosciences Inc shares valued at $228,186 were sold by Bensen Daniel on Jan 12 ’26. At $28.52 per share, Bensen Daniel sold 8,000 shares. The insider’s holdings dropped to 154,981 shares worth approximately $4.79 million following the completion of this transaction.
Also, Daniel Bensen purchased 8,000 shares, netting a total of over 232,000 in proceeds.
Before that, MORE ROBERT J had sold 10,000 shares from its account. In a trade valued at $250,000, the Director traded Tyra Biosciences Inc shares for $25.00 each. Upon closing the transaction, the insider’s holdings decreased to 10,000 shares, worth approximately $118.18 million.
As published in their initiating research note from Raymond James on September 03, 2025, Tyra Biosciences Inc [TYRA] has been a Strong buy and the price target has been revised to $35. As of January 07, 2025, UBS has initiated its “Buy” rating for TYRA. Earlier on October 18, 2024, BofA Securities upgraded its rating. Their new recommendation was “a Buy” for TYRA stock which previously was a “a Neutral”.
Analyzing TYRA Stock Performance
On last trading session, Tyra Biosciences Inc [NASDAQ: TYRA] rose 5.03% to $30.91. The stock’s lowest price that day was $29.3, but it reached a high of $31.4 in the same session. During the last five days, there has been a surge of approximately 5.86%. Over the course of the year, Tyra Biosciences Inc shares have jumped approximately 94.28%.
Is Tyra Biosciences Inc subject to short interest?
Stocks of Tyra Biosciences Inc saw a sharp rise in short interest on 2025-12-31 jumping by 1.64 million shares to 5.79 million. Data from Yahoo Finance shows that the short interest on 2025-11-28 was 4.15 million shares. A jump of 28.4% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 11.29 of the overall float, the days-to-cover ratio (short ratio) jumped to 11.29.
Which companies own the most shares of Tyra Biosciences Inc (TYRA)?
In terms of Tyra Biosciences Inc share price expectations, FactSet research, analysts set an average price target of 36.5 in the next 12 months, up nearly 24.02% from the previous closing price of $29.43. Analysts anticipate Tyra Biosciences Inc stock to reach 37 by 2026, with the lowest price target being 36. In spite of this, 2 analysts ranked Tyra Biosciences Inc stock as Buy at the end of 2026. On August 15, 2024, Piper Sandler assigned a price target of “an Overweight” to the stock and initiated coverage with a $33.
